Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Priority claimed from PCT/EP1995/001801external-prioritypatent/WO1995031963A1/en
Publication of MX9605709ApublicationCriticalpatent/MX9605709A/es
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invencion se refiere a composiciones que constan de flubendazol de formula (I), que son sabrosas para los animales de compañía, especialmente los perros. Estas son utiles como composiciones antihélmiticas sabrosas para el tratamiento de la helmintiasis. (Ver Formula).
MX9605709A1995-05-121995-05-12Tabletas masticables de flubendazol para animales de compañia.
MX9605709A
(es)
4-bencil-1,3-dihidro-imidazol-2-tionas substituidas y no substituidas que actuan como agonistas adrenergicos alfa2 especificos o selectivos y metodos de uso de las mismas.